Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. It distributes automated workflow solutions for research and clinical diagnostics laboratories in the life sciences sector. Tellgen produces the products for tumor, infectious and reproductive disease diagnostics. The company was founded on November 6, 2003 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company